Skip to main content
Erschienen in: Molecular Diagnosis & Therapy 4/2016

01.08.2016 | Original Research Article

Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome

verfasst von: Mariana Burgos, Alvaro Arenas, Rodrigo Cabrera

Erschienen in: Molecular Diagnosis & Therapy | Ausgabe 4/2016

Einloggen, um Zugang zu erhalten

Abstract

Background and Objective

Inherited long QT syndrome (LQTS) is a cardiac channelopathy characterized by a prolongation of QT interval and the risk of syncope, cardiac arrest, and sudden cardiac death. Genetic diagnosis of LQTS is critical in medical practice as results can guide adequate management of patients and distinguish phenocopies such as catecholaminergic polymorphic ventricular tachycardia (CPVT). However, extensive screening of large genomic regions is required in order to reliably identify genetic causes. Semiconductor whole exome sequencing (WES) is a promising approach for the identification of variants in the coding regions of most human genes.

Methods

DNA samples from 21 Colombian patients clinically diagnosed with LQTS were enriched for coding regions using multiplex polymerase chain reaction (PCR) and subjected to WES using a semiconductor sequencer.

Results

Semiconductor WES showed mean coverage of 93.6 % for all coding regions relevant to LQTS at >10× depth with high intra- and inter-assay depth heterogeneity. Fifteen variants were detected in 12 patients in genes associated with LQTS. Three variants were identified in three patients in genes associated with CPVT. Co-segregation analysis was performed when possible. All variants were analyzed with two pathogenicity prediction algorithms. The overall prevalence of LQTS and CPVT variants in our cohort was 71.4 %. All LQTS variants previously identified through commercial genetic testing were identified.

Conclusion

Standardized WES assays can be easily implemented, often at a lower cost than sequencing panels. Our results show that WES can identify LQTS-causing mutations and permits differential diagnosis of related conditions in a real-world clinical setting. However, high heterogeneity in sequencing depth and low coverage in the most relevant genes is expected to be associated with reduced analytical sensitivity.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
2.
Zurück zum Zitat Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761–7.CrossRefPubMedPubMedCentral Schwartz PJ, Stramba-Badiale M, Crotti L, Pedrazzini M, Besana A, Bosi G, et al. Prevalence of the congenital long-QT syndrome. Circulation. 2009;120:1761–7.CrossRefPubMedPubMedCentral
3.
Zurück zum Zitat Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet. 2013;21:918–28.CrossRefPubMedPubMedCentral Andreasen C, Nielsen JB, Refsgaard L, Holst AG, Christensen AH, Andreasen L, et al. New population-based exome data are questioning the pathogenicity of previously cardiomyopathy-associated genetic variants. Eur J Hum Genet. 2013;21:918–28.CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Refsgaard L, Holst AG, Sadjadieh G, Haunsø S, Nielsen JB, Olesen MS. High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet. 2012;20:905–8.CrossRefPubMedPubMedCentral Refsgaard L, Holst AG, Sadjadieh G, Haunsø S, Nielsen JB, Olesen MS. High prevalence of genetic variants previously associated with LQT syndrome in new exome data. Eur J Hum Genet. 2012;20:905–8.CrossRefPubMedPubMedCentral
5.
Zurück zum Zitat Spoonamore KG, Ware SM. Genetic testing and genetic counseling in patients with sudden death risk due to heritable arrhythmias. Heart Rhythm. 2016;13:789–97.CrossRefPubMed Spoonamore KG, Ware SM. Genetic testing and genetic counseling in patients with sudden death risk due to heritable arrhythmias. Heart Rhythm. 2016;13:789–97.CrossRefPubMed
6.
Zurück zum Zitat Millat G, Chanavat V, Rousson R. Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeqTM library and ion torrent PGMTM sequencing for the rapid detection of genetic variations in long QT syndrome. Mol Diagn Ther. 2014;18:533–9.CrossRefPubMed Millat G, Chanavat V, Rousson R. Evaluation of a new high-throughput next-generation sequencing method based on a custom AmpliSeqTM library and ion torrent PGMTM sequencing for the rapid detection of genetic variations in long QT syndrome. Mol Diagn Ther. 2014;18:533–9.CrossRefPubMed
7.
Zurück zum Zitat Ruan Y, Liu N, Napolitano C, Priori SG. Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol. 2008;1:290–7.CrossRefPubMed Ruan Y, Liu N, Napolitano C, Priori SG. Therapeutic strategies for long-QT syndrome: does the molecular substrate matter? Circ Arrhythm Electrophysiol. 2008;1:290–7.CrossRefPubMed
8.
Zurück zum Zitat Abriel H, Zaklyazminskaya EV. Cardiac channelopathies: genetic and molecular mechanisms. Gene. 2013;517:1–11.CrossRefPubMed Abriel H, Zaklyazminskaya EV. Cardiac channelopathies: genetic and molecular mechanisms. Gene. 2013;517:1–11.CrossRefPubMed
9.
Zurück zum Zitat Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764–8.CrossRefPubMed Tester DJ, Will ML, Haglund CM, Ackerman MJ. Effect of clinical phenotype on yield of long QT syndrome genetic testing. J Am Coll Cardiol. 2006;47:764–8.CrossRefPubMed
10.
Zurück zum Zitat Tanaka Y, Kawabata M, Scheinman MM, Hirao K. Catecholaminergic polymorphic ventricular tachycardia with QT Prolongation. Pacing Clin Electrophysiol. 2015;38:1499–502.CrossRefPubMed Tanaka Y, Kawabata M, Scheinman MM, Hirao K. Catecholaminergic polymorphic ventricular tachycardia with QT Prolongation. Pacing Clin Electrophysiol. 2015;38:1499–502.CrossRefPubMed
11.
Zurück zum Zitat Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69–74.CrossRefPubMed Priori SG, Napolitano C, Memmi M, Colombi B, Drago F, Gasparini M, et al. Clinical and molecular characterization of patients with catecholaminergic polymorphic ventricular tachycardia. Circulation. 2002;106:69–74.CrossRefPubMed
12.
Zurück zum Zitat Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm. 2005;2:1099–105.CrossRefPubMed Tester DJ, Kopplin LJ, Will ML, Ackerman MJ. Spectrum and prevalence of cardiac ryanodine receptor (RyR2) mutations in a cohort of unrelated patients referred explicitly for long QT syndrome genetic testing. Heart Rhythm. 2005;2:1099–105.CrossRefPubMed
13.
14.
Zurück zum Zitat Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA. 2005;294:2975–80.CrossRefPubMed Napolitano C, Priori SG, Schwartz PJ, Bloise R, Ronchetti E, Nastoli J, et al. Genetic testing in the long QT syndrome: development and validation of an efficient approach to genotyping in clinical practice. JAMA. 2005;294:2975–80.CrossRefPubMed
15.
Zurück zum Zitat Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95.CrossRefPubMed Schwartz PJ, Priori SG, Spazzolini C, Moss AJ, Vincent GM, Napolitano C, et al. Genotype-phenotype correlation in the long-QT syndrome: gene-specific triggers for life-threatening arrhythmias. Circulation. 2001;103:89–95.CrossRefPubMed
16.
Zurück zum Zitat Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745–55.CrossRefPubMed Bamshad MJ, Ng SB, Bigham AW, Tabor HK, Emond MJ, Nickerson DA, et al. Exome sequencing as a tool for Mendelian disease gene discovery. Nat Rev Genet. 2011;12:745–55.CrossRefPubMed
17.
Zurück zum Zitat Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame muta. J Am Coll Cardiol. 2009;54:2065–74.CrossRefPubMedPubMedCentral Medeiros-Domingo A, Bhuiyan ZA, Tester DJ, Hofman N, Bikker H, van Tintelen JP, et al. The RYR2-encoded ryanodine receptor/calcium release channel in patients diagnosed previously with either catecholaminergic polymorphic ventricular tachycardia or genotype negative, exercise-induced long QT syndrome: a comprehensive open reading frame muta. J Am Coll Cardiol. 2009;54:2065–74.CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Kolder ICRM, Tanck MWT, Postema PG, Barc J, Sinner MF, Zumhagen S, et al. Analysis for Genetic modifiers of disease severity in patients with long-QT syndrome Type 2. Circ Cardiovasc Genet. 2015;8:447–56.CrossRefPubMedPubMedCentral Kolder ICRM, Tanck MWT, Postema PG, Barc J, Sinner MF, Zumhagen S, et al. Analysis for Genetic modifiers of disease severity in patients with long-QT syndrome Type 2. Circ Cardiovasc Genet. 2015;8:447–56.CrossRefPubMedPubMedCentral
20.
Zurück zum Zitat Aiba T, Ishibashi K, Wada M, Nakajima I, Miyamoto K, Okamura H, et al. Clinical significance of whole exome analysis using next generation sequencing in the genotype-negative long-QT syndrome. Circulation. 2014;130:A13817. Aiba T, Ishibashi K, Wada M, Nakajima I, Miyamoto K, Okamura H, et al. Clinical significance of whole exome analysis using next generation sequencing in the genotype-negative long-QT syndrome. Circulation. 2014;130:A13817.
21.
Zurück zum Zitat Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, et al. Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. PLoS One. 2015;10:e0130329.CrossRefPubMedPubMedCentral Shigemizu D, Aiba T, Nakagawa H, Ozaki K, Miya F, Satake W, et al. Exome analyses of long QT syndrome reveal candidate pathogenic mutations in calmodulin-interacting genes. PLoS One. 2015;10:e0130329.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475:348–52.CrossRefPubMed Rothberg JM, Hinz W, Rearick TM, Schultz J, Mileski W, Davey M, et al. An integrated semiconductor device enabling non-optical genome sequencing. Nature. 2011;475:348–52.CrossRefPubMed
23.
Zurück zum Zitat Elkadri A, Thoeni C, Deharvengt SJ, Murchie R, Guo C, Stavropoulos JD, et al. Mutations in plasmalemma vesicle associated protein result in sieving protein-losing enteropathy characterized by hypoproteinemia, hypoalbuminemia, and hypertriglyceridemia. Cell Mol Gastroenterol Hepatol. 2015;1(381–94):e7.PubMed Elkadri A, Thoeni C, Deharvengt SJ, Murchie R, Guo C, Stavropoulos JD, et al. Mutations in plasmalemma vesicle associated protein result in sieving protein-losing enteropathy characterized by hypoproteinemia, hypoalbuminemia, and hypertriglyceridemia. Cell Mol Gastroenterol Hepatol. 2015;1(381–94):e7.PubMed
24.
Zurück zum Zitat Gómez J, Reguero JR, Morís C, Alvarez V, Coto E. Non optical semi-conductor next generation sequencing of the main cardiac QT-interval duration genes in pooled DNA samples. J Cardiovasc Transl Res. 2014;7:133–7.CrossRefPubMed Gómez J, Reguero JR, Morís C, Alvarez V, Coto E. Non optical semi-conductor next generation sequencing of the main cardiac QT-interval duration genes in pooled DNA samples. J Cardiovasc Transl Res. 2014;7:133–7.CrossRefPubMed
25.
Zurück zum Zitat Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27:2987–93.CrossRefPubMedPubMedCentral Li H. A statistical framework for SNP calling, mutation discovery, association mapping and population genetical parameter estimation from sequencing data. Bioinformatics. 2011;27:2987–93.CrossRefPubMedPubMedCentral
26.
27.
Zurück zum Zitat Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielsk E, et al. dbSNP: the NCBI database of genetic variation. Nucl Acids Res. 2001;29:308–11.CrossRefPubMedPubMedCentral Sherry S, Ward M, Kholodov M, Baker J, Phan L, Smigielsk E, et al. dbSNP: the NCBI database of genetic variation. Nucl Acids Res. 2001;29:308–11.CrossRefPubMedPubMedCentral
29.
Zurück zum Zitat Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucl Acids Res. 2014;42:D980–5.CrossRefPubMed Landrum MJ, Lee JM, Riley GR, Jang W, Rubinstein WS, Church DM, et al. ClinVar: public archive of relationships among sequence variation and human phenotype. Nucl Acids Res. 2014;42:D980–5.CrossRefPubMed
30.
Zurück zum Zitat Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.CrossRefPubMedPubMedCentral Adzhubei IA, Schmidt S, Peshkin L, Ramensky VE, Gerasimova A, Bork P, et al. A method and server for predicting damaging missense mutations. Nat Methods. 2010;7:248–9.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.CrossRefPubMed Kumar P, Henikoff S, Ng PC. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat Protoc. 2009;4:1073–81.CrossRefPubMed
32.
Zurück zum Zitat Varela A, Arenas A, Cabrera R, Burgos M. Denervación simpática cardiaca izquierda como coadyuvante en el tratamiento del sindrome de QT largo en pediatría. 2015. Varela A, Arenas A, Cabrera R, Burgos M. Denervación simpática cardiaca izquierda como coadyuvante en el tratamiento del sindrome de QT largo en pediatría. 2015.
33.
Zurück zum Zitat Ackerman MJ. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue. Heart Rhythm. 2015;12:2325–31.CrossRefPubMed Ackerman MJ. Genetic purgatory and the cardiac channelopathies: Exposing the variants of uncertain/unknown significance issue. Heart Rhythm. 2015;12:2325–31.CrossRefPubMed
34.
Zurück zum Zitat Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009;6:1297–303.CrossRefPubMedPubMedCentral Kapplinger JD, Tester DJ, Salisbury BA, Carr JL, Harris-Kerr C, Pollevick GD, et al. Spectrum and prevalence of mutations from the first 2,500 consecutive unrelated patients referred for the FAMILION long QT syndrome genetic test. Heart Rhythm. 2009;6:1297–303.CrossRefPubMedPubMedCentral
35.
Zurück zum Zitat Hedley PL, Durrheim GA, Hendricks F, Goosen A, Jespersgaard C, Støvring B, et al. Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr. 2013;24:231–7.CrossRefPubMedPubMedCentral Hedley PL, Durrheim GA, Hendricks F, Goosen A, Jespersgaard C, Støvring B, et al. Long QT syndrome in South Africa: the results of comprehensive genetic screening. Cardiovasc J Afr. 2013;24:231–7.CrossRefPubMedPubMedCentral
36.
Zurück zum Zitat Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, et al. Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm. 2010;7:1411–8.CrossRefPubMed Itoh H, Shimizu W, Hayashi K, Yamagata K, Sakaguchi T, Ohno S, et al. Long QT syndrome with compound mutations is associated with a more severe phenotype: a Japanese multicenter study. Heart Rhythm. 2010;7:1411–8.CrossRefPubMed
37.
Zurück zum Zitat Winbo A, Stattin E-L, Diamant U-B, Persson J, Jensen SM, Rydberg A. Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. Europace. 2012;14:1799–806.CrossRefPubMed Winbo A, Stattin E-L, Diamant U-B, Persson J, Jensen SM, Rydberg A. Prevalence, mutation spectrum, and cardiac phenotype of the Jervell and Lange-Nielsen syndrome in Sweden. Europace. 2012;14:1799–806.CrossRefPubMed
38.
Zurück zum Zitat Dausse E, Berthet M, Denjoy I, André-Fouet X, Cruaud C, Bennaceur M, et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol. 1996;28:1609–15.CrossRefPubMed Dausse E, Berthet M, Denjoy I, André-Fouet X, Cruaud C, Bennaceur M, et al. A mutation in HERG associated with notched T waves in long QT syndrome. J Mol Cell Cardiol. 1996;28:1609–15.CrossRefPubMed
39.
Zurück zum Zitat Priori SG, Schwartz PJ, Napolitano C, Bianchi L, Dennis A, Fusco MD, et al. A recessive variant of the Romano-Ward long-QT syndrome? Circulation. 1998;97:2420–5.CrossRefPubMed Priori SG, Schwartz PJ, Napolitano C, Bianchi L, Dennis A, Fusco MD, et al. A recessive variant of the Romano-Ward long-QT syndrome? Circulation. 1998;97:2420–5.CrossRefPubMed
40.
Zurück zum Zitat Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 1997;96:2778–81.CrossRefPubMed Donger C, Denjoy I, Berthet M, Neyroud N, Cruaud C, Bennaceur M, et al. KVLQT1 C-terminal missense mutation causes a forme fruste long-QT syndrome. Circulation. 1997;96:2778–81.CrossRefPubMed
41.
Zurück zum Zitat Nakajima T, Furukawa T, Hirano Y, Tanaka T, Sakurada H, Takahashi T, et al. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc Res. 1999;44:283–93.CrossRefPubMed Nakajima T, Furukawa T, Hirano Y, Tanaka T, Sakurada H, Takahashi T, et al. Voltage-shift of the current activation in HERG S4 mutation (R534C) in LQT2. Cardiovasc Res. 1999;44:283–93.CrossRefPubMed
42.
Zurück zum Zitat Russell MW, Dick M, Collins FS, Brody LC. KVLQT1 mutations in three families with familial or sporadic long QT syndrome. Hum Mol Genet. 1996;5:1319–24.CrossRefPubMed Russell MW, Dick M, Collins FS, Brody LC. KVLQT1 mutations in three families with familial or sporadic long QT syndrome. Hum Mol Genet. 1996;5:1319–24.CrossRefPubMed
Metadaten
Titel
Semiconductor Whole Exome Sequencing for the Identification of Genetic Variants in Colombian Patients Clinically Diagnosed with Long QT Syndrome
verfasst von
Mariana Burgos
Alvaro Arenas
Rodrigo Cabrera
Publikationsdatum
01.08.2016
Verlag
Springer International Publishing
Erschienen in
Molecular Diagnosis & Therapy / Ausgabe 4/2016
Print ISSN: 1177-1062
Elektronische ISSN: 1179-2000
DOI
https://doi.org/10.1007/s40291-016-0207-2

Weitere Artikel der Ausgabe 4/2016

Molecular Diagnosis & Therapy 4/2016 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Erhebliches Risiko für Kehlkopfkrebs bei mäßiger Dysplasie

29.05.2024 Larynxkarzinom Nachrichten

Fast ein Viertel der Personen mit mäßig dysplastischen Stimmlippenläsionen entwickelt einen Kehlkopftumor. Solche Personen benötigen daher eine besonders enge ärztliche Überwachung.

Nach Herzinfarkt mit Typ-1-Diabetes schlechtere Karten als mit Typ 2?

29.05.2024 Herzinfarkt Nachrichten

Bei Menschen mit Typ-2-Diabetes sind die Chancen, einen Myokardinfarkt zu überleben, in den letzten 15 Jahren deutlich gestiegen – nicht jedoch bei Betroffenen mit Typ 1.

15% bedauern gewählte Blasenkrebs-Therapie

29.05.2024 Urothelkarzinom Nachrichten

Ob Patienten und Patientinnen mit neu diagnostiziertem Blasenkrebs ein Jahr später Bedauern über die Therapieentscheidung empfinden, wird einer Studie aus England zufolge von der Radikalität und dem Erfolg des Eingriffs beeinflusst.

Costims – das nächste heiße Ding in der Krebstherapie?

28.05.2024 Onkologische Immuntherapie Nachrichten

„Kalte“ Tumoren werden heiß – CD28-kostimulatorische Antikörper sollen dies ermöglichen. Am besten könnten diese in Kombination mit BiTEs und Checkpointhemmern wirken. Erste klinische Studien laufen bereits.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.